Year |
Citation |
Score |
2019 |
Guo R, Berry LD, Aisner DL, Sheren J, Boyle T, Bunn PA, Johnson BE, Kwiatkowski DJ, Drilon A, Sholl LM, Kris MG. MET IHC is a Poor Screen for MET Amplification or MET exon 14 mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 31228623 DOI: 10.1016/J.Jtho.2019.06.009 |
0.341 |
|
2016 |
Turner J, Couts K, Sheren J, Saichaemchan S, Ariyawutyakorn W, Avolio I, Cabral E, Glogowska M, Amato C, Robinson S, Hintzsche J, Applegate A, Seelenfreund E, Gonzalez R, Wells K, et al. Kinase Gene Fusions in Defined Subsets of Melanoma. Pigment Cell & Melanoma Research. PMID 27864876 DOI: 10.1111/Pcmr.12560 |
0.37 |
|
2015 |
Becker AP, Scapulatempo-Neto C, Carloni AC, Paulino A, Sheren J, Aisner DL, Musselwhite E, Clara C, Machado HR, Oliveira RS, Neder L, Varella-Garcia M, Reis RM. KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas. Journal of Neuropathology and Experimental Neurology. 74: 743-54. PMID 26083571 DOI: 10.1097/Nen.0000000000000213 |
0.354 |
|
2014 |
Varella-Garcia M, Becker AP, Sheren J, Neto CS, Aisner D, Bidinotto L, Neder L, Jones C, Reis RM. Characterization of KIAA1549:BRAF fusion in young pilocytic astrocytoma patients through fluorescence in situ hybridization. Journal of Clinical Oncology. 32: 10067-10067. DOI: 10.1200/Jco.2014.32.15_Suppl.10067 |
0.347 |
|
2007 |
Sheren J, Langer SJ, Leinwand LA. A randomized library approach to identifying functional lox site domains for the Cre recombinase. Nucleic Acids Research. 35: 5464-73. PMID 17702764 DOI: 10.1093/Nar/Gkm604 |
0.473 |
|
2005 |
Sheren JE, Ketner E, Keith J, Langer SJ, Leinwand LA. 1099. Beyond LoxP: Defining Functional Lox-Like Sequences for the Cre Recombinase Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.647 |
0.475 |
|
Show low-probability matches. |